Unknown

Dataset Information

0

Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women.


ABSTRACT: Osteoprotegerin (OPG) is a soluble decoy receptor for receptor activator nuclear factor kappa-beta that blocks osteoclastic bone resorption.We investigated the association between a Lys3Asn polymorphism in the OPG gene and bone mineral density (BMD), and the risk of fracture in 6695 women aged 65 yr and older participating in the Study of Osteoporotic Fractures.BMD was measured using either single-photon absorptiometry (Osteon Osteoanalyzer; Dove Medical Group, Los Angeles, CA) or dual-energy x-ray absorptiometry (Hologic QDR 1000; Hologic, Inc., Bedford, MA). Incident fractures were confirmed by physician adjudication of radiology reports. Genotyping was performed using an immobilized probe-based assay.Women who were homozygous for the minor G (Lys) allele had significantly lower BMD at the intertrochanter, distal radius, lumbar spine, and calcaneus than those with the C (Asn) allele. There were 701 incident hip fractures during 13.6-yr follow-up (91,249 person-years), including 362 femoral neck and 333 intertrochanteric hip fractures. Women with the C/C (Asn-Asn) genotype had a 51% higher risk of femoral neck fracture (95% confidence interval, 1.13-2.02) and 26% higher risk of hip fracture (95% confidence interval, 1.02-1.54) than those with the G/G (Lys-Lys) genotype. These associations were independent of BMD. Intertrochanteric fractures were not associated with the Lys3Asn polymorphism.These results require confirmation but suggest a role for the OPG Lys3Asn polymorphism in the genetic susceptibility to hip fractures among older white women.

SUBMITTER: Moffett SP 

PROVIDER: S-EPMC2386283 | biostudies-literature | 2008 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women.

Moffett S P SP   Oakley J I JI   Cauley J A JA   Lui L Y LY   Ensrud K E KE   Taylor B C BC   Hillier T A TA   Hochberg M C MC   Li J J   Cayabyab S S   Lee J M JM   Peltz G G   Cummings S R SR   Zmuda J M JM  

The Journal of clinical endocrinology and metabolism 20080304 5


<h4>Context</h4>Osteoprotegerin (OPG) is a soluble decoy receptor for receptor activator nuclear factor kappa-beta that blocks osteoclastic bone resorption.<h4>Objective</h4>We investigated the association between a Lys3Asn polymorphism in the OPG gene and bone mineral density (BMD), and the risk of fracture in 6695 women aged 65 yr and older participating in the Study of Osteoporotic Fractures.<h4>Design</h4>BMD was measured using either single-photon absorptiometry (Osteon Osteoanalyzer; Dove  ...[more]

Similar Datasets

| S-EPMC6332293 | biostudies-literature
| S-EPMC11304123 | biostudies-literature
| S-EPMC9395308 | biostudies-literature
| S-EPMC8436954 | biostudies-literature
| S-EPMC9233980 | biostudies-literature
| S-EPMC6115713 | biostudies-literature
| S-EPMC4561195 | biostudies-literature
| S-EPMC8758616 | biostudies-literature
| S-EPMC4729209 | biostudies-other
| S-EPMC4126739 | biostudies-literature